$PBH
Prestige Consumer Healthcare Inc Stock $pbh

$pbh Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000129594722000023 Filed on August 04, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$289.3M	$277.1M	$266.9M
YoY Change	4.72%	2.93%	12.25%
Cost Of Revenue	$128.3M	$116.9M	$118.1M
YoY Change	8.23%	6.15%	17.25%
Gross Profit	$161.0M	$160.1M	$148.9M
YoY Change	2.09%	0.7%	8.58%
Gross Profit Margin	55.66%	57.79%	55.77%
Selling, General & Admin	$70.26M	$66.67M	$64.75M
YoY Change	-3.73%	7.68%	7.55%
% of Gross Profit	43.64%	41.63%	43.49%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$6.368M	$8.384M	$8.485M
YoY Change	-20.03%	10.4%	11.64%
% of Gross Profit	3.96%	5.24%	5.7%
Operating Expenses	$76.63M	$73.11M	$71.44M
YoY Change	-3.2%	8.03%	7.91%
Operating Profit	$84.38M	$87.01M	$77.43M
YoY Change	7.42%	-4.74%	9.2%
Interest Expense	-$16.98M	-$15.29M	-$15.97M
YoY Change	4.08%	1.43%	-15.93%
% of Operating Profit	-20.12%	-17.57%	-20.63%
Other Income/Expense, Net	-$812.0K	-$825.0K	-$487.0K
YoY Change	64.71%	-885.71%	-169.57%
Pretax Income	$66.59M	$70.90M	$60.97M
YoY Change	11.68%	-7.17%	50.9%
Income Tax	$15.57M	$15.63M	$8.879M
% Of Pretax Income	23.38%	22.04%	14.56%
Net Earnings	$51.02M	$55.27M	$52.09M
YoY Change	12.57%	-4.3%	46.72%
Net Earnings / Revenue	17.64%	19.95%	19.51%
Basic Earnings Per Share	$1.02	$1.10
Diluted Earnings Per Share	$1.02	$1.09	$1.022M
COMMON SHARES
Basic Shares Outstanding	49.76M shares	50.26M shares	50.20M shares
Diluted Shares Outstanding	50.27M shares	50.73M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$42.44M	$35.87M	$27.19M
YoY Change	-0.88%	-78.08%	-15.84%
Cash & Equivalents	$42.44M	$35.87M	$27.19M
Short-Term Investments
Other Short-Term Assets	$7.714M	$9.527M	$6.410M
YoY Change	2.57%	5.76%	-18.86%
Inventory	$140.5M	$133.8M	$120.3M
Prepaid Expenses
Receivables	$146.0M	$145.5M	$139.3M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$336.7M	$324.6M	$293.3M
YoY Change	10.45%	-20.54%	8.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$69.95M	$70.39M	$71.30M
YoY Change	-0.11%	0.81%	1.77%
Goodwill	$575.6M	$576.8M	$579.0M
YoY Change	-0.56%	-0.18%	0.16%
Intangibles	$2.671B	$2.683B	$2.697B
YoY Change	-0.71%	8.62%	8.92%
Long-Term Investments
YoY Change
Other Assets	$2.577M	$2.743M	$3.273M
YoY Change	0.55%	8.76%	14.32%
Total Long-Term Assets	$3.342B	$3.358B	$3.377B
YoY Change	-0.86%	6.57%	6.9%
TOTAL ASSETS
Total Short-Term Assets	$336.7M	$324.6M	$293.3M
Total Long-Term Assets	$3.342B	$3.358B	$3.377B
Total Assets	$3.679B	$3.682B	$3.671B
YoY Change	0.07%	3.46%	7.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$56.20M	$58.11M	$55.76M
YoY Change	47.7%	87.68%	21.28%
Accrued Expenses	$80.86M	$80.64M	$82.24M
YoY Change	-19.71%	-3.66%	14.38%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.793M	$2.772M	$2.752M
YoY Change	-53.45%	6.33%
Total Short-Term Liabilities	$152.3M	$155.3M	$143.4M
YoY Change	2.26%	24.23%	17.43%
LONG-TERM LIABILITIES
Long-Term Debt	$1.455B	$1.490B	$1.495B
YoY Change	-9.85%	-3.58%	1.04%
Other Long-Term Liabilities	$8.877M	$8.918M	$7.484M
YoY Change	4.57%	4.24%	-13.1%
Total Long-Term Liabilities	$1.464B	$1.499B	$1.502B
YoY Change	-9.78%	-3.54%	0.96%
TOTAL LIABILITIES
Total Short-Term Liabilities	$152.3M	$155.3M	$143.4M
Total Long-Term Liabilities	$1.464B	$1.499B	$1.502B
Total Liabilities	$2.059B	$2.097B	$2.093B
YoY Change	-7.02%	-2.12%	1.07%
SHAREHOLDERS EQUITY
Retained Earnings	$1.320B	$1.269B	$1.214B
YoY Change	18.76%	19.02%	20.36%
Common Stock	$547.0K	$547.0K	$544.0K
YoY Change	0.92%	0.92%	0.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$189.1M	$176.8M	$133.6M
YoY Change	41.49%	32.31%	2.23%
Treasury Stock Shares	5.164M shares	4.928M shares	4.151M shares
Shareholders Equity	$1.620B	$1.585B	$1.578B
YoY Change
Total Liabilities & Shareholders Equity	$3.679B	$3.682B	$3.671B
YoY Change	0.07%	3.46%	7.04%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	$51.02M	$55.27M	$52.09M
YoY Change	12.57%	-4.3%	46.72%
Depreciation, Depletion And Amortization	$6.368M	$8.384M	$8.485M
YoY Change	-20.03%	10.4%	11.64%
Cash From Operating Activities	$57.54M	$58.25M	$63.13M
YoY Change	-5.97%	-15.96%	6.81%
INVESTING ACTIVITIES
Capital Expenditures	-$2.376M	$1.047M	-$3.161M
YoY Change	-13.66%	-30.2%	-35.49%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	-$132.0K
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	-$2.376M	-$1.047M	-$3.293M
YoY Change	-98.97%	-20.86%	-32.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$37.73M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-47.96M	-$47.37M	-54.12M
YoY Change	-194.9%	-174.43%	-35.35%
NET CHANGE
Cash From Operating Activities	57.54M	$58.25M	63.13M
Cash From Investing Activities	-2.376M	-$1.047M	-3.293M
Cash From Financing Activities	-47.96M	-$47.37M	-54.12M
Net Change In Cash	7.208M	$8.684M	5.718M
YoY Change	-106.01%	-93.39%	-119.38%
FREE CASH FLOW
Cash From Operating Activities	$57.54M	$58.25M	$63.13M
Capital Expenditures	-$2.376M	$1.047M	-$3.161M
Free Cash Flow	$59.92M	$57.20M	$66.29M
YoY Change	-6.3%	-15.64%	3.57%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q1	us-gaap	Derivative Number Of Instruments Held DerivativeNumberOfInstrumentsHeld	1	agreement
CY2022Q2	dei	Document Type DocumentType	10-Q
CY2022Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001295947
CY2022Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2022Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q2	dei	Amendment Flag AmendmentFlag	false
CY2022Q2	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
CY2022Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q2	dei	Entity File Number EntityFileNumber	001-32433
CY2022Q2	dei	Entity Registrant Name EntityRegistrantName	PRESTIGE CONSUMER HEALTHCARE INC.
CY2022Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-1297589
CY2022Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	660 White Plains Road
CY2022Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	Tarrytown
CY2022Q2	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10591
CY2022Q2	dei	City Area Code CityAreaCode	914
CY2022Q2	dei	Local Phone Number LocalPhoneNumber	524-6800
CY2022Q2	dei	Security12b Title Security12bTitle	Common stock, par value $0.01 per share
CY2022Q2	dei	Trading Symbol TradingSymbol	PBH
CY2022Q2	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q2	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q2	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q2	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	49762633	shares
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	277059000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	269181000	usd
CY2022Q2	pbh	Cost Of Sales Exclusive Of Depreciation CostOfSalesExclusiveOfDepreciation	114996000	usd
CY2021Q2	pbh	Cost Of Sales Exclusive Of Depreciation CostOfSalesExclusiveOfDepreciation	108335000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	1944000	usd
CY2021Q2	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	1834000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	116940000	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	110169000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	160119000	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	159012000	usd
CY2022Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	39951000	usd
CY2021Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	39439000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	26714000	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22471000	usd
CY2022Q2	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	6440000	usd
CY2021Q2	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	5760000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	73105000	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	67670000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	87014000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	91342000	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-15292000	usd
CY2021Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-15077000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-825000	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	105000	usd
CY2022Q2	pbh	Total Other Income Expense TotalOtherIncomeExpense	-16117000	usd
CY2021Q2	pbh	Total Other Income Expense TotalOtherIncomeExpense	-14972000	usd
CY2022Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	70897000	usd
CY2021Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	76370000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15625000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18615000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	55272000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	57755000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.10
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.15
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.09
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.14
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50264000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50139000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50730000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50671000	shares
CY2022Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-9519000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1492000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	0	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	520000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	790000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	0	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-10309000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-972000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	44963000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	56783000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35869000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27185000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	576794000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	18335000	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	19720000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	145451000	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	139330000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	133768000	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	120342000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9527000	usd
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6410000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	324615000	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	293267000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	70393000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	71300000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	18885000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	20372000	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	6193000	usd
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	6858000	usd
CY2022Q1	us-gaap	Assets Assets	3670681000	usd
CY2022Q1	us-gaap	Goodwill Goodwill	578976000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2682611000	usd
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2696635000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2743000	usd
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3273000	usd
CY2022Q2	us-gaap	Assets Assets	3682234000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	58110000	usd
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	55760000	usd
CY2022Q2	us-gaap	Interest And Dividends Payable Current InterestAndDividendsPayableCurrent	15182000	usd
CY2022Q1	us-gaap	Interest And Dividends Payable Current InterestAndDividendsPayableCurrent	4437000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6548000	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6360000	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2772000	usd
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2752000	usd
CY2022Q2	pbh	Accrued And Other Liabilities Current AccruedAndOtherLiabilitiesCurrent	72737000	usd
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q1	pbh	Accrued And Other Liabilities Current AccruedAndOtherLiabilitiesCurrent	74113000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	155349000	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	143422000	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	1472427000	usd
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	1476658000	usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	442537000	usd
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	444917000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	14460000	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	16088000	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3800000	usd
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	4501000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8918000	usd
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7484000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	2097491000	usd
CY2022Q1	us-gaap	Liabilities Liabilities	2093070000	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3670681000	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54690000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54430000	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	547000	usd
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	544000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	520926000	usd
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	515583000	usd
CY2022Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	4928000	shares
CY2022Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	4151000	shares
CY2022Q2	us-gaap	Treasury Stock Value TreasuryStockValue	176825000	usd
CY2022Q1	us-gaap	Treasury Stock Value TreasuryStockValue	133648000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-29341000	usd
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-19032000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1269436000	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1214164000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1584743000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1577611000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3682234000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1584743000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1577611000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3857000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1489000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	43177000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	55272000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-10309000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	1358298000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1878000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2204000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2021Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	2916000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	57755000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-972000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	1416247000	usd
CY2022Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7079000	usd
CY2021Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	15879000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	55272000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	57755000	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8384000	usd
CY2021Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7594000	usd
CY2022Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-13000	usd
CY2021Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-26000	usd
CY2022Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1213000	usd
CY2021Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	5876000	usd
CY2022Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	828000	usd
CY2021Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	759000	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	3857000	usd
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1878000	usd
CY2022Q2	pbh	Additions To Operating Lease Right Of Use Assets AdditionsToOperatingLeaseRightOfUseAssets	1493000	usd
CY2021Q2	pbh	Additions To Operating Lease Right Of Use Assets AdditionsToOperatingLeaseRightOfUseAssets	1691000	usd
CY2022Q2	us-gaap	Other Noncash Expense OtherNoncashExpense	446000	usd
CY2021Q2	us-gaap	Other Noncash Expense OtherNoncashExpense	0	usd
CY2022Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	10524000	usd
CY2022Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	14415000	usd
CY2021Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-9384000	usd
CY2022Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3227000	usd
CY2021Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1049000	usd
CY2022Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2542000	usd
CY2021Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-15551000	usd
CY2021Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	18439000	usd
CY2022Q2	pbh	Increase Decrease In Operating Leases Liabilities IncreaseDecreaseInOperatingLeasesLiabilities	-1602000	usd
CY2021Q2	pbh	Increase Decrease In Operating Leases Liabilities IncreaseDecreaseInOperatingLeasesLiabilities	-1578000	usd
CY2022Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	2000	usd
CY2021Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	40000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	58247000	usd
CY2021Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	69305000	usd
CY2022Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1047000	usd
CY2021Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1500000	usd
CY2022Q2	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	usd
CY2021Q2	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-177000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1047000	usd
CY2021Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1323000	usd
CY2022Q2	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	15000000	usd
CY2021Q2	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	20000000	usd
CY2022Q2	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	20000000	usd
CY2021Q2	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	85000000	usd
CY2022Q2	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	10000000	usd
CY2021Q2	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2022Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	686000	usd
CY2021Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	638000	usd
CY2022Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1489000	usd
CY2021Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2204000	usd
CY2022Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	5450000	usd
CY2021Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2916000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32302000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35869000	usd
CY2022Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	37727000	usd
CY2021Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-47374000	usd
CY2021Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	63650000	usd
CY2022Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1142000	usd
CY2021Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-310000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8684000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	131322000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27185000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	163624000	usd
CY2022Q2	us-gaap	Interest Paid Net InterestPaidNet	3562000	usd
CY2021Q2	us-gaap	Interest Paid Net InterestPaidNet	3389000	usd
CY2022Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid	1799000	usd
CY2021Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid	2388000	usd
CY2022Q2	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates. Our most significant estimates include those made in connection with the valuation of intangible assets, stock-based </span></div>compensation, fair value of debt, sales returns and allowances, trade promotional allowances, inventory obsolescence, and accounting for income taxes and related uncertain tax positions.
CY2022Q2	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	16737000	usd
CY2022Q1	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	16984000	usd
CY2022Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	476000	usd
CY2022Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	338000	usd
CY2022Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	116555000	usd
CY2022Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	103020000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	133768000	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	120342000	usd
CY2022Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	4900000	usd
CY2022Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	4900000	usd
CY2022Q1	us-gaap	Goodwill Gross GoodwillGross	744274000	usd
CY2022Q1	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	165298000	usd
CY2022Q1	us-gaap	Goodwill Goodwill	578976000	usd
CY2022Q2	us-gaap	Goodwill Transfers GoodwillTransfers	550000	usd
CY2022Q2	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-1632000	usd
CY2022Q2	us-gaap	Goodwill Gross GoodwillGross	742092000	usd
CY2022Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	165298000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	576794000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	300000	usd
CY2022Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2912733000	usd
CY2022Q2	pbh	Intangible Assets Acquired IntangibleAssetsAcquired	0	usd
CY2022Q2	pbh	Intangible Assets Translation Adjustments Gain Loss IntangibleAssetsTranslationAdjustmentsGainLoss	-8572000	usd
CY2022Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2904161000	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	216098000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5635000	usd
CY2022Q2	pbh	Finite Lived Intangible Assets Accumulated Amortization Translation Adjustments Gain Loss FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss	183000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	221550000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2682611000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5600000	usd
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4900000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	16865000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	22445000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	20392000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	18145000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	16504000	usd
CY2022Q2	pbh	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	118497000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	212848000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	700000	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	665000	usd
CY2021Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	642000	usd
CY2022Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	50000	usd
CY2021Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	66000	usd
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	1634000	usd
CY2021Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	1687000	usd
CY2022Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	34000	usd
CY2021Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	22000	usd
CY2022Q2	us-gaap	Variable Lease Cost VariableLeaseCost	11999000	usd
CY2021Q2	us-gaap	Variable Lease Cost VariableLeaseCost	11651000	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	14382000	usd
CY2021Q2	us-gaap	Lease Cost LeaseCost	14068000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1883000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	80000	usd
CY2022Q2	pbh	Operating And Finance Lease Liability Payments Due Year Four OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour	1963000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	5382000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	2191000	usd
CY2022Q2	pbh	Operating And Finance Lease Liability Payments Remainder Of Fiscal Year OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	7573000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	6850000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	2923000	usd
CY2022Q2	pbh	Operating And Finance Lease Liability Payments Due Year One OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne	9773000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4586000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	1509000	usd
CY2022Q2	pbh	Operating And Finance Lease Liability Payments Due Year Two OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo	6095000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2181000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	96000	usd
CY2022Q2	pbh	Operating And Finance Lease Liability Payments Due Year Three OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree	2277000	usd
CY2022Q2	pbh	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	1682000	usd
CY2022Q2	pbh	Finance Lease Liability To Be Paid Due After Year Four FinanceLeaseLiabilityToBePaidDueAfterYearFour	0	usd
CY2022Q2	pbh	Operating And Finance Lease Liability Payments Due After Year Four OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour	1682000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	22564000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	6799000	usd
CY2022Q2	pbh	Operating And Finance Lease Liability Payment Due OperatingAndFinanceLeaseLiabilityPaymentDue	29363000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1556000	usd
CY2022Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	227000	usd
CY2022Q2	pbh	Operating And Finance Lease Liability Undiscounted Excess Amount OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount	1783000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	21008000	usd
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	6572000	usd
CY2022Q2	pbh	Operating And Finance Lease Liability OperatingAndFinanceLeaseLiability	27580000	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y9M21D
CY2022Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y4M24D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0308
CY2022Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0295
CY2022Q2	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	37835000	usd
CY2022Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	36149000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5356000	usd
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	19587000	usd
CY2022Q2	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	1239000	usd
CY2022Q1	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	1179000	usd
CY2022Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	13830000	usd
CY2022Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2670000	usd
CY2022Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3965000	usd
CY2022Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4150000	usd
CY2022Q2	pbh	Accrued Production Costs Current AccruedProductionCostsCurrent	3225000	usd
CY2022Q1	pbh	Accrued Production Costs Current AccruedProductionCostsCurrent	3686000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7287000	usd
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6692000	usd
CY2022Q2	pbh	Accrued And Other Liabilities Current AccruedAndOtherLiabilitiesCurrent	72737000	usd
CY2022Q1	pbh	Accrued And Other Liabilities Current AccruedAndOtherLiabilitiesCurrent	74113000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1490000000	usd
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1495000000	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	17573000	usd
CY2022Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	18342000	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	1472427000	usd
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	1476658000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	10000000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	usd
CY2022Q2	pbh	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	1480000000	usd
CY2022Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1490000000	usd
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q2	pbh	Voting Rights Number Of Votes Per Common Share Owned VotingRightsNumberOfVotesPerCommonShareOwned	1	vote
CY2022Q2	us-gaap	Dividends Common Stock DividendsCommonStock	0	usd
CY2021	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	0	usd
CY2022Q2	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	0	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	55272000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	57755000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50264000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50139000	shares
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	466000	shares
CY2021Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	532000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50730000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50671000	shares
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.10
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.15
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.09
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.14
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee	1000000	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee	2500000	shares
CY2014Q2	pbh	Share Based Compensation Arrangement By Share Based Payment Award Extension Of Expiration Period ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod	P10Y
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3857000	usd
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1878000	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	537000	usd
CY2021Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	143000	usd
CY2022Q2	pbh	Share Based Compensation Arrangement By Share Based Payment Award Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue	10225000	usd
CY2021Q2	pbh	Share Based Compensation Arrangement By Share Based Payment Award Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue	7006000	usd
CY2022Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1489000	usd
CY2021Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2204000	usd
CY2022Q2	pbh	Effective Income Tax Rate Reconciliation Deduction Restricted Stock Issuances And Stock Options Amount EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount	2895000	usd
CY2022Q2	pbh	Number Of Third Party Manufacturers NumberOfThirdPartyManufacturers	129	manufacturer
CY2021Q2	pbh	Effective Income Tax Rate Reconciliation Deduction Restricted Stock Issuances And Stock Options Amount EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount	1721000	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	5500000	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y4M24D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	2200000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1114900	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	37.92
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	222700	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	44.33
CY2021Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	67900	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	32.49
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	9200	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	36.45
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	8400	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	56.63
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1252100	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	39.24
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y10M24D
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	17068000	usd
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	779500	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	38.72
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y7M6D
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	11399000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1100900	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	40.62
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	197600	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	54.48
CY2022Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	39100	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	38.04
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1259400	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	42.88
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y10M24D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	20052000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	827000.0	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	39.98
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y8M12D
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	15567000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	700000	usd
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.220
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.244
CY2022Q2	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	331000	usd
CY2021Q2	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	278000	usd
CY2022Q2	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	252000	usd
CY2021Q2	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	290000	usd
CY2022Q2	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	79000	usd
CY2021Q2	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	-12000	usd
CY2022Q2	pbh	Defined Benefit Plan Plan Assets Payment For Settlement Lump Sum DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum	13800000	usd
CY2022Q2	pbh	Defined Benefit Plan Plan Assets Payment For Settlement Purchase Of Annuity Contract DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract	31100000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Finalization Of Pension And Non Pension Postretirement Plan Valuation Before Tax OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax	-400000	usd
CY2021Q2	pbh	Number Of Third Party Manufacturers NumberOfThirdPartyManufacturers	118	manufacturer
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	277059000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	116940000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	160119000	usd
CY2022Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	39951000	usd
CY2022Q2	pbh	Contribution Margin ContributionMargin	120168000	usd
CY2022Q2	pbh	General And Administrative And Depreciation And Amortization Expense GeneralAndAdministrativeAndDepreciationAndAmortizationExpense	33154000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	87014000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	269181000	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	110169000	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	159012000	usd
CY2021Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	39439000	usd
CY2021Q2	pbh	Contribution Margin ContributionMargin	119573000	usd
CY2021Q2	pbh	General And Administrative And Depreciation And Amortization Expense GeneralAndAdministrativeAndDepreciationAndAmortizationExpense	28231000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	91342000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	277059000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	269181000	usd

Files In Submission

Name	View Source	Status
0001295947-22-000023-index-headers.html	Edgar Link	pending
0001295947-22-000023-index.html	Edgar Link	pending
0001295947-22-000023.txt	Edgar Link	pending
0001295947-22-000023-xbrl.zip	Edgar Link	pending
exhibit3112022-06x30.htm	Edgar Link	pending
exhibit3122022-06x30.htm	Edgar Link	pending
exhibit3212022-06x30.htm	Edgar Link	pending
exhibit3222022-06x30.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pbh-20220630.htm	Edgar Link	pending
pbh-20220630.xsd	Edgar Link	pending
pbh-20220630_cal.xml	Edgar Link	unprocessable
pbh-20220630_def.xml	Edgar Link	unprocessable
pbh-20220630_g1.jpg	Edgar Link	pending
pbh-20220630_htm.xml	Edgar Link	completed
pbh-20220630_lab.xml	Edgar Link	unprocessable
pbh-20220630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PBH
Prestige Consumer Healthcare Inc Stock $pbh

2022 Q3 Form 10-Q Financial Statement

#000129594722000023 Filed on August 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PBH Prestige Consumer Healthcare Inc Stock $pbh

2022 Q3 Form 10-Q Financial Statement

#000129594722000023 Filed on August 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PBH
Prestige Consumer Healthcare Inc Stock $pbh